GlassScriptPhysician profile
Jeffrey Michael Martinez
NPI 1295731164
$16,731.19
in general payments reported to CMS, 2019-2025
30 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,318 · 2020: $614 · 2021: $1,109 · 2022: $1,832 · 2023: $872 · 2024: $9,854 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Food and Beverage: $4,393 · Travel and Lodging: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Food and Beverage | $4,393.17 |
| Travel and Lodging | $866.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $8,142.79 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $2,353.88 | 2019-2025 | General - Vascular Intervention, Eluvia, Wavewriter Alpha Prime 16 |
| Cardiovascular Systems INC. | $881.80 | 2019-2021 | |
| Abbott Laboratories | $780.71 | 2021-2025 | Esprit, Absolute Pro |
| Veryan Medical Incorporated | $556.64 | 2020-2025 | Biomimics 3d Vascular Stent System |
| Biotronik INC. | $544.42 | 2022-2025 | Passeo-18, Pulsar-18 T3, Orsiro Mission |
| Medtronic Vascular, INC. | $528.20 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $518.27 | 2021-2024 | Xarelto |
| Cook Medical LLC | $324.61 | 2024-2025 | Torcon Nb, Tornado, Zilver Ptx |
| Medtronic, INC. | $315.64 | 2021-2022 | |
| Philips North America LLC | $278.43 | 2019-2023 | |
| Angiodynamics, INC. | $220.94 | 2022 | |
| Provisio Medical, INC. | $215.41 | 2024 | |
| Janssen Scientific Affairs, LLC | $124.99 | 2021 | |
| Smith+Nephew, INC. | $124.98 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $110.17 | 2023 | Puraply |
| Endologix LLC | $106.94 | 2020 | |
| Bolton Medical INC | $80.18 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Lexington Medical, INC. | $75.66 | 2023 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Cagent Vascular INC | $73.45 | 2024 | Serrantor |
| Cordis US Corp. | $68.29 | 2023 | |
| Terumo Medical Corporation | $58.60 | 2019 | |
| Tactile Systems Technology INC | $48.83 | 2020-2025 | Nimbl, Flexitouch Plus |
| Becton, Dickinson and Company | $38.38 | 2025 | Lutonix Drug Coated Balloon, Crosser Iq |
| Penumbra, INC. | $31.52 | 2024 | Indigo System |
| Avinger INC. | $31.01 | 2021 | |
| Surmodics, INC. | $27.55 | 2022 | |
| Cardiva Medical, INC. | $27.35 | 2024 | Cardiva Vascade 6/7f Vcs |
| Teleflex LLC | $20.82 | 2025 | Pulsar-18 T3 |
| Inari Medical, INC. | $20.73 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$129,051.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.